Expression of oncogenic ras in human teratocarcinoma cells induces partial differentiation and permissiveness for human cytomegalovirus infection.

Retinoic acid (RA)-induced differentiation of human teratocarcinoma (T2) cells results in a change from a normally non-permissive phenotype for human cytomegalovirus (HCMV) infection to cells which are fully permissive. We have used this system to analyse factors associated with differentiation which may regulate HCMV gene expression. Differentiation of T2 cells results in an increase of c-ras expression. Consequently, we have introduced ras expression vectors into T2 cells. We find that, as with RA induction, transfection of T2 cells with oncogenic human Ha-ras results in cells which are permissive for HCMV infection and gene expression. However, unlike RA which induces a cessation of cell proliferation and terminal differentiation, ras transfection only appears to result in changes associated with early events in RA-induced differentiation of T2 cells.

[1]  A. Raap,et al.  Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition , 1986, Journal of virology.

[2]  R. Ohlsson,et al.  Cancer genes, proto-oncogenes, and development. , 1987, Experimental cell research.

[3]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[4]  B. Fleckenstein,et al.  Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. , 1986, The EMBO journal.

[5]  P. Andrews,et al.  Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. , 1984, Science.

[6]  J. Nelson,et al.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene , 1987, Molecular and cellular biology.

[7]  D. Swartzendruber,et al.  Neoplastic differentiation: Interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro , 1975, Journal of cellular physiology.

[8]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[9]  G. Hayward,et al.  Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells , 1986, Journal of virology.

[10]  D. Bar-Sagi,et al.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation , 1985, Cell.

[11]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.

[12]  B. Roizman,et al.  Regulation of Herpesvirus Macromolecular Synthesis I. Cascade Regulation of the Synthesis of Three Groups of Viral Proteins , 1974, Journal of virology.

[13]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[14]  B. Wasylyk,et al.  The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer , 1987, Cell.

[15]  E. Wagner,et al.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes , 1984, Nature.

[16]  C. Malone,et al.  Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter , 1987, Journal of virology.

[17]  N C Dracopoli,et al.  Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[18]  P. Stern,et al.  Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. , 1984, Journal of cell science.

[19]  M. Groudine,et al.  Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites , 1986, Molecular and cellular biology.

[20]  J. Nevins,et al.  Developmental control of a promoter-specific factor that is also regulated by the E1A gene product , 1987, Cell.